4D5M

Gonadotropin-releasing hormone agonist

External Resource: Annotation

Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations
Protein Modification Annotation

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D	PF00446	Gonadotropin-releasing hormone (GnRH)	Gonadotropin-releasing hormone	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	TRIPTORELIN	hormone activity protein binding binding molecular function activator activity signaling receptor binding molecular function regulator activity signaling receptor regulator activity receptor ligand activity signaling receptor activator activity peptide hormone receptor binding gonadotropin-releasing hormone receptor binding hormone receptor binding gonadotropin hormone-releasing hormone activity	developmental process multicellular organismal process regulation of biological process gonad development reproductive system development regulation of developmental process reproductive process female gonad development sex differentiation biological regulation animal organ development female sex differentiation development of primary female sexual characteristics regulation of ovarian follicle development developmental process involved in reproduction developmental process multicellular organismal process regulation of biological process gonad development reproductive system development regulation of developmental process reproductive process female gonad development sex differentiation biological regulation animal organ development female sex differentiation development of primary female sexual characteristics regulation of ovarian follicle development developmental process involved in reproduction multicellular organism development development of primary sexual characteristics anatomical structure development reproductive structure development ovarian follicle development system development response to lipid response to stimulus response to hormone response to steroid hormone response to chemical response to endogenous stimulus response to organic cyclic compound regulation of biosynthetic process regulation of cellular process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process regulation of gene expression biosynthetic process regulation of macromolecule biosynthetic process metabolic process cellular process macromolecule metabolic process regulation of metabolic process signaling cell-cell signaling cell communication negative regulation of locomotion regulation of cell motility cellular developmental process negative regulation of biological process negative regulation of neuron migration regulation of neuron migration neurogenesis cell differentiation regulation of cell migration negative regulation of cellular process cell migration cell motility locomotion negative regulation of cell migration neuron migration nervous system development generation of neurons regulation of locomotion negative regulation of cell motility cellular response to stimulus signal transduction response to alcohol response to oxygen-containing compound response to ethanol	cellular anatomical structure extracellular region extracellular space

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR019792	Gonadoliberin	Family
A, B, C, D	IPR002012	Gonadotropin-releasing hormone	Conserved Site
A, B, C, D	IPR004079	Gonadoliberin I precursor	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D	Pharos: P01148	acquired hyperprolactinemia hypogonadism hypogonadotropic hypogonadism 12 with or without anosmia hypogonadotropic hypogonadism Idiopathic Hypogonadotropic Hypogonadism Klinefelter syndrome precocious puberty male infertility adult acute respiratory distress syndrome Kallmann syndrome hypertensive disorder ovarian hyperstimulation syndrome anovulation breast cancer hyperandrogenism acquired hyperprolactinemia hypogonadism hypogonadotropic hypogonadism 12 with or without anosmia hypogonadotropic hypogonadism Idiopathic Hypogonadotropic Hypogonadism Klinefelter syndrome precocious puberty male infertility adult acute respiratory distress syndrome Kallmann syndrome hypertensive disorder ovarian hyperstimulation syndrome anovulation breast cancer hyperandrogenism infertility disorder central precocious puberty hyperprolactinemia hypogonadotropic hypogonadism 7 with or without anosmia osteosarcoma adrenal gland cancer polycystic ovary syndrome amenorrhea psoriasis endometriosis

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B, C, D	DTR	RESID: AA0198 PSI-MOD : D-tryptophan MOD:00205
A, B, C, D	NH2	RESID: AA0198 , AA0081 , AA0083 , AA0084 , AA0086 , AA0087 , AA0088 , AA0090 , AA0091 , AA0092 , AA0093 , AA0095 , AA0096 , AA0097 , AA0098 , AA0099 , AA0100 PSI-MOD : D-tryptophan MOD:00205 , L-alanine amide MOD:00090 , L-asparagine amide MOD:00092 , L-aspartic acid 1-amide MOD:00093 , L-glutamine amide MOD:00095 , L-glutamic acid 1-amide MOD:00096 , glycine amide MOD:00097 , L-isoleucine amide MOD:00099 , L-leucine amide MOD:00100 , L-lysine amide MOD:00101 , L-methionine amide MOD:00102 , L-proline amide MOD:00104 , L-serine amide MOD:00105 , L-threonine amide MOD:00106 , L-tryptophan amide MOD:00107 , L-tyrosine amide MOD:00108 , L-valine amide MOD:00109
A, B, C, D	PCA	Parent Component: GLN RESID: AA0198 , AA0081 , AA0083 , AA0084 , AA0086 , AA0087 , AA0088 , AA0090 , AA0091 , AA0092 , AA0093 , AA0095 , AA0096 , AA0097 , AA0098 , AA0099 , AA0100 , AA0031 PSI-MOD : D-tryptophan MOD:00205 , L-alanine amide MOD:00090 , L-asparagine amide MOD:00092 , L-aspartic acid 1-amide MOD:00093 , L-glutamine amide MOD:00095 , L-glutamic acid 1-amide MOD:00096 , glycine amide MOD:00097 , L-isoleucine amide MOD:00099 , L-leucine amide MOD:00100 , L-lysine amide MOD:00101 , L-methionine amide MOD:00102 , L-proline amide MOD:00104 , L-serine amide MOD:00105 , L-threonine amide MOD:00106 , L-tryptophan amide MOD:00107 , L-tyrosine amide MOD:00108 , L-valine amide MOD:00109 , 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.